Jeena Sikho Lifecare Limited has informed the Exchange about General Updates
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare Limited has informed the exchanges about two academic publications authored by its medical team, including Managing Director Manish Grover. The first is a case study titled 'Ayurvedic Management of Type 2 Diabetes Mellitus' published in the European Journal of Pharmaceutical and Medical Research, showing a 45-year-old female patient's blood sugar falling from 159 to 129 mg/dl, HbA1c improving from 7.3% to 6.4%, and notable normalisation of cholesterol and triglycerides after three months of Ayurvedic treatment. The second is a research article titled 'Integrative Hope in Advanced Chronic Kidney Disease: An Ayurvedic Case Approach' published in the International Journal of Advanced Research (IJAR). The company describes this as part of its commitment to advancing Ayurvedic research and evidence-based clinical practices.
This is a soft, brand-building disclosure with no direct financial or operational impact on the company. It may modestly support the company's credibility in the Ayurvedic healthcare space, but investors should not expect any near-term effect on revenue, margins, or stock price from academic publications alone.